Research output per year
Research output per year
Personal profile
Education/Academic qualification
Farmasia, Farmaseutti
External positions
Osastofarmaseutti, HUS-Apteekki
22 Oct 2020 → 4 Dec 2020
Osastofarmaseutti, HUS-Apteekki
14 May 2020 → 30 Aug 2020
Farmaseutti, Farenta oy
1 Jun 2016 → 11 Aug 2019
Fields of Science
- 3111 Biomedicine
International and National Collaboration
Publications and projects within past five years.
-
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor alpha Antagonist Infliximab in Pediatric Inflammatory Bowel Disease
Höyhtyä, M., Korpela, K., Saqib, S., Junkkari, S., Nissila, E., Nikkonen, A., Dikareva, E., Salonen, A., de Vos, W. M. & Kolho, K.-L., Jan 2023, In: Inflammatory Bowel Diseases. 29, 1, p. 116–124 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Reduced binding of apoE4 to complement factor H promotes amyloid-beta oligomerization and neuroinflammation
Chernyaeva, L., Ratti, G., Teirilä, L., Fudo, S., Rankka, U., Pelkonen, A., Korhonen, P., Leskinen, K., Keskitalo, S., Salokas, K., Gkolfinopoulou, C., Crompton, K. E., Javanainen, M., Happonen, L., Varjosalo, M., Malm, T., Leinonen, V., Chroni, A., Saavalainen, P. & Meri, S. & 4 others, , 5 Jul 2023, In: EMBO Reports. 24, 7, 23 p., e56467.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease
Ventin-Holmberg, R., Eberl, A., Saqib, S., Korpela, K., Virtanen, S., Salonen, A., Sipponen, T. M., Saavalainen, P. & Nissilä, E., 22 Jun 2021, In: Journal of Crohn's and Colitis. 15, 6, p. 1019-1031 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
Syed, S., Nissilä, E., Ruhanen, H., Fudo, S., Gaytan, M. O., Sihvo, S. P., Lorey, M. B., Metso, J., Oorni, K., King, S. J., Oommen, O. P., Jauhiainen, M., Meri, S., Käkelä, R. & Haapasalo, K., 25 Jun 2021, In: iScience. 24, 6, 21 p., 102535.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Gut microbiota composition as a predictor of infliximab treatment response in inflammatory bowel disease patients
Nissilä, E., Ventin-Holmberg, R., Sipponen, T., Salonen, A. & Saavalainen, P., 2019.Research output: Conference materials › Abstract › peer-review
Projects
- 1 Active
-
Juselius 2022 Meri
Meri, S. (Project manager), Chen, C. (Participant), Dulipati Syrjänen, V. (Participant), Lokki, A. I. (Participant), Nissilä, E. (Participant) & Roquigny, J. (Participant)
Sigrid Juséliuksen Säätiö @003701165704@
01/05/2022 → 30/04/2025
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
Activities
-
APMIS : Acta pathologica, microbiologica et immunologica Scandinavica (Journal)
Nissilä, E. (Reviewer)
27 Mar 2023Activity: Publication peer-review and editorial work types › Peer review of manuscripts
-
Frontiers in cardiovascular medicine (Journal)
Nissilä, E. (Reviewer)
2 Mar 2023Activity: Publication peer-review and editorial work types › Peer review of manuscripts
-
Life (Basel) (Journal)
Nissilä, E. (Reviewer)
26 Jul 2022Activity: Publication peer-review and editorial work types › Peer review of manuscripts
-
the 18th European Meeting on Complement in Human Disease
Nissilä, E. (Attendee)
26 Aug 2022 → 29 Aug 2022Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars
-
Journal of Crohn's and Colitis (Journal)
Nissilä, E. (Reviewer)
25 Feb 2021Activity: Publication peer-review and editorial work types › Peer review of manuscripts
Press/Media
-
Suolistomikrobien tunnistaminen vähentäisi turhia IBD:n lääkityksiä – ”Tutkimuksemme perusteella lääke ei tehoa joka kolmannelle potilaalle”
Nissilä, E. & Ventin-Holmberg, R.
15/02/2021
1 item of Media coverage
Press/Media: Press / Media
-
Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals
01/02/2021
1 item of Media coverage
Press/Media: Press / Media
-
Suoliston mikrobisto paljastaa, toimiiko lääkehoito tulehduksellisissa suolistosairauksissa
26/01/2021
1 item of Media coverage
Press/Media: Press / Media